PMDA drug package insert
ラモトリギン錠小児用2mg「サワイ」
PMDA Prescription drug · 沢井製薬株式会社 · package insert Aug 27, 2026
Key facts
| Brand names | ラモトリギン錠小児用2mg「サワイ」, ラモトリギン錠小児用5mg「サワイ」, ラモトリギン錠25mg「サワイ」, ラモトリギン錠100mg「サワイ」 |
|---|---|
| Nonproprietary names | ラモトリギン |
| Companies | 製造販売元／沢井製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 抗てんかん剤（錠小児用2mg、錠小児用5mg）; 抗てんかん剤、双極性障害治療薬（錠25mg、錠100mg） |
| Therapeutic category codes | 871139, 871179 |
| YJ codes | 1139009F1030, 1139009F2036, 1139009F3059, 1139009F4055 |
| Approval numbers | 23000AMX00245000, 23000AMX00247000, 23000AMX00244000, 23000AMX00246000 |
| Package insert edition | 第5版 |
| Package insert date | Aug 27, 2026 |
| PMDA document key | 300119_1139009F1030_1 |
| PMDA company code | 300119 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: